The most talked about and market moving research calls around Wall Street are now in one place.
Here are today’s research calls that investors need to know, as compiled by The Fly
Top 5 Upgrades: – Arete upgraded Meta Platforms (META) to Buy from Neutral with a price target of $735, up from $614. The firm cites Meta’s “flexible” cost base, subscription growth, and internal AI progress for the upgrade. – Wedbush upgraded TripAdvisor (TRIP) to Outperform from Neutral with a price target of $19, up from $12, following a transfer in analyst coverage. TripAdvisor has “underappreciated catalysts,” including its governance transformation that eliminated controlled-company status, activist involvement by Starboard Value, a strategic review process for TheFork, and an “emerging AI narrative” given its “large and valuable” travel dataset and recently signed partnership deals with OpenAI, the firm tells investors in a research note. – Wedbush upgraded Abivax (ABVX) to Neutral from Underperform with a price target of $90, down from $110.
The firm notes the company reported placebo-adjusted maintenance clinical remission rates of 40% above its benchmark expectations of 20%-30%, but disclosed malignancies at the higher dose of 50 mg QD, which increases risk for an eventual black box warning, and prior to approval, an FDA AdComm. – Susquehanna upgraded Knight-Swift (KNX) to Positive from Neutral with a price target of $90, up from $72. The firm cites the company’s growing contribution from less than truckload and its “higher-quality” earnings mix for the upgrade. – Raymond James upgraded Atlas Energy (AESI) to Outperform from Market Perform with a $25 price target. The company’s Q1 results brought clarity around its “materially increased” distributed power growth plans, the firm tells investors in a research note.